Medical Neolistat Powder 99% CAS 282526-98-1 Cetilistat

China Medical Neolistat Powder 99% CAS 282526-98-1 Cetilistat, Find details about China Neolistat, Neolistat Powder from Medical Neolistat Powder 99% CAS 282526-98-1 Cetilistat

Model NO.
YT0432
Appearance
White Powder
MOQ
10gram
Shelf Life
2 Years
Test Method
HPLC
Sample
Availiable
Packing
Vacuum Packed, Drum
Storage
Sealed in Dry, 2-8°c
Molecular Formula
C25h39no3
Molecular Weight
401.58
Einecs
1308068-626-2
Melting Point
72.0 to 76.0 °c
Boiling Point
509.7±43.0 °c(Predicted)
Trademark
YTBIO
Specification
99%
Origin
Shaanxi, China
Model NO.
YT0432
Appearance
White Powder
MOQ
10gram
Shelf Life
2 Years
Test Method
HPLC
Sample
Availiable
Packing
Vacuum Packed, Drum
Storage
Sealed in Dry, 2-8°c
Molecular Formula
C25h39no3
Molecular Weight
401.58
Einecs
1308068-626-2
Melting Point
72.0 to 76.0 °c
Boiling Point
509.7±43.0 °c(Predicted)
Trademark
YTBIO
Specification
99%
Origin
Shaanxi, China
Medical Neolistat Powder 99% CAS 282526-98-1 Cetilistat
Medical Neolistat Powder 99% CAS 282526-98-1 CetilistatCetilistat (atl-962), also known as cetilistat, is a new gastrointestinal lipase inhibitor developed by alizyme
company in the UK. Later, "norgina bv" company obtained the global agency right of "cetilistat chemicalbook".
Cetiriestat is in phase 3 clinical trial in the United States. In Japan, due to cooperation with Takeda pharmaceutical,
xinlistat was approved as a drug for the treatment of obesity in September 2013. The trade name is "oblean".
Product Name
Cetilistat 
CAS No.
282526-98-1
M.F.
C25H39NO3
M.W.
401.58
EINECS No
1308068-626-2
Appearance
White powder
Purity
99%
Package
Bag/drum/OEM
Medical Neolistat Powder 99% CAS 282526-98-1 CetilistatNeolistat is a long-acting and powerful specific gastrointestinal lipase inhibitor. It plays a therapeutic role by
forming covalent bonds with the active serine sites of gastric lipase and pancreatic lipase in the stomach and
small intestine. The inactivated enzyme cannot hydrolyze the fat in food, mainly triglycerides, into absorbable
free fatty acids and monoacylglycerides, Undigested triglycerides cannot be absorbed by the body, so as to
reduce calorie intake and control weight.

Medical Neolistat Powder 99% CAS 282526-98-1 Cetilistat
New lestar is a new type of pancreatic lipase inhibitor used to treat obesity in diabetic and non-diabetic patients.
Main purpose:
1. New weight loss drugs
2. It can be used to quit smoking

Medical Neolistat Powder 99% CAS 282526-98-1 Cetilistat
Medical Neolistat Powder 99% CAS 282526-98-1 CetilistatMedical Neolistat Powder 99% CAS 282526-98-1 CetilistatMedical Neolistat Powder 99% CAS 282526-98-1 CetilistatMedical Neolistat Powder 99% CAS 282526-98-1 CetilistatMedical Neolistat Powder 99% CAS 282526-98-1 CetilistatMedical Neolistat Powder 99% CAS 282526-98-1 Cetilistat